AU2002249304A1 - Novel human gnrh receptor - Google Patents

Novel human gnrh receptor

Info

Publication number: AU2002249304A1
Authority: AU; Australia
Prior art keywords: novel human; gnrh receptor; human gnrh; receptor; novel
Prior art date: 2001-03-01
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2002249304A

Other languages

English (en)

Other versions

AU2002249304A8 (en

Inventor

Eric Ferrandis

Christophe Thurieau

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Ipsen Pharma SAS

Original Assignee

Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-01

Filing date

2002-03-01

Publication date

2002-09-19

2001-03-01 Priority claimed from FR0102802A external-priority patent/FR2821619A1/fr

2001-05-22 Priority claimed from FR0106760A external-priority patent/FR2825094A1/fr

2002-03-01 Application filed by Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS filed Critical Societe de Conseils de Recherches et dApplications Scientifiques SCRAS SAS

2002-09-19 Publication of AU2002249304A1 publication Critical patent/AU2002249304A1/en

2007-08-30 Publication of AU2002249304A8 publication Critical patent/AU2002249304A8/xx

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Endocrinology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Microbiology (AREA)
Biotechnology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Reproductive Health (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

AU2002249304A 2001-03-01 2002-03-01 Novel human gnrh receptor Abandoned AU2002249304A1 (en)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
FR01/02802		2001-03-01
FR0102802A FR2821619A1 (fr)	2001-03-01	2001-03-01	Nouveau recepteur gnrh humain
FR0106760A FR2825094A1 (fr)	2001-05-22	2001-05-22	Nouveau recepteur gnrh humain et ses applications
FR01/06760		2001-05-22
FR01/06763		2001-05-22
FR0106763		2001-05-22
PCT/FR2002/000741 WO2002070701A2 (fr)	2001-03-01	2002-03-01	Nouveau recepteur gnrh humain

Publications (2)

Publication Number	Publication Date
AU2002249304A1 true AU2002249304A1 (en)	2002-09-19
AU2002249304A8 AU2002249304A8 (en)	2007-08-30

Family

ID=27248748

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002249304A Abandoned AU2002249304A1 (en)	2001-03-01	2002-03-01	Novel human gnrh receptor

Country Status (2)

Country	Link
AU (1)	AU2002249304A1 (fr)
WO (1)	WO2002070701A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2003260313A1 (en) *	2002-07-22	2004-02-09	Bayer Healthcare Ag	Human gnrh (type 2) receptor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3719712B2 (ja) *	1992-06-23	2005-11-24	ザマウントシナイスクールオブメディシンオブザシティーユニバーシティーオブニューヨーク	ゴナドトロピン放出ホルモン受容体のクローニングおよび発現
US5677184A (en) *	1994-04-19	1997-10-14	Takeda Chemical Industries, Ltd.	CHO cells that express human LH-RH receptor
WO1997047743A1 (fr) *	1996-06-13	1997-12-18	Zymogenetics, Inc.	Recepteur humain de l'hormone de liberation de la gonadotrophine de type ii
KR20020097218A (ko) *	2000-04-15	2002-12-31	메디칼 리서취 카운실	타입 ⅱ 고나도트로핀-방출 호르몬 수용체 및 이를엔코딩하는 폴리누클레오티드

2002
- 2002-03-01 WO PCT/FR2002/000741 patent/WO2002070701A2/fr not_active Ceased
- 2002-03-01 AU AU2002249304A patent/AU2002249304A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2002070701A3 (fr)	2003-10-09
WO2002070701A2 (fr)	2002-09-12
WO2002070701A9 (fr)	2007-06-28
AU2002249304A8 (en)	2007-08-30

Publication	Publication Date	Title
AU2002328762A1 (en)	2003-07-03	Osteophilic implants
AU2002310044A1 (en)	2002-12-09	Headwall
AU2002317759A1 (en)	2002-12-03	Ophthalmoscope
AU2002252460A1 (en)	2002-10-08	Human cytokine receptor
AU2001272974A1 (en)	2002-01-02	Human receptors
AU2002365093A1 (en)	2003-07-09	Therapeutic compositions
AUPR600601A0 (en)	2001-07-26	Therapeutic compositions
AU2002227925A1 (en)	2002-05-27	Human beta-defensin-3
AU2001277980A1 (en)	2002-02-05	Human cytokine receptor
AU2002358719A1 (en)	2003-07-15	Agaricoglycerides and analogs
AU2002250041A1 (en)	2002-08-28	Putative human enzymes
AU2002367281A1 (en)	2003-07-24	Isolated cytokine receptor licr-2
WO2003006609A9 (fr)	2010-01-21	Recepteur de cytokines humain
AU2002249304A1 (en)	2002-09-19	Novel human gnrh receptor
AU2002346030A1 (en)	2003-01-21	Novel receptors
WO2002077001A9 (fr)	2013-10-31	Nouveaux recepteurs
AU2002354842A1 (en)	2003-03-03	Novel human proton-gated channels
AU2002344325A1 (en)	2002-11-25	Isolated human g protein-coupled receptor
AU2001266932A1 (en)	2002-01-08	Human lyases
AU2003260313A1 (en)	2004-02-09	Human gnrh (type 2) receptor
AU2002257630A1 (en)	2002-09-24	Human mrp5-like protein
GB0128161D0 (en)	2002-01-16	Receptor protein
AU2002338920A1 (en)	2003-05-12	Improved endoprosthetic device
AUPR969801A0 (en)	2002-01-24	Therapeutic compounds - ii
AU2002359260A1 (en)	2003-04-22	A human g protein coupled receptor

Legal Events

Date	Code	Title	Description
2004-02-12	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase